Literature DB >> 20876467

Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up.

M P Amato1, B Goretti, A Ghezzi, S Lori, V Zipoli, L Moiola, M Falautano, M F De Caro, R Viterbo, F Patti, R Vecchio, C Pozzilli, V Bianchi, M Roscio, V Martinelli, G Comi, E Portaccio, M Trojano.   

Abstract

OBJECTIVE: To assess the evolution of cognitive and psychosocial functioning in a cohort of childhood and juvenile multiple sclerosis (MS) cases after a mean period of 2 years had elapsed since baseline evaluation.
METHODS: In this cohort study, we used the same extensive neuropsychological battery with alternative versions of the tests assessing memory, attention/concentration, executive functions, and language. Fatigue and depression were also measured. An interview on school and daily living activities was obtained from the parents. The cognitive performance of the patients was compared with that of demographically matched healthy controls (HC).
RESULTS: Fifty-six patients and 50 HC were assessed. At follow-up, criteria for cognitive impairment (failure on at least 3 tests) were fulfilled in 39 patients (70%) and 75% of the cases were classified as having a deteriorating cognitive performance. Changes were prominent in tests of verbal memory, complex attention, verbal fluency, and receptive language. In the regression analysis, the only significant predictor of cognitive deterioration was older age of the subject (odds ratio 1.9, 95% confidence interval 1.2-2.9, p = 0.003). Psychiatric disorders, most frequently depression, were diagnosed in 12 patients (30.5%). Fatigue was reported by 21% of the patients. MS negatively affected school and everyday activities in 30% to 40% of the subjects.
CONCLUSIONS: Our findings confirm the importance of systematic assessment of cognitive and psychosocial issues in children and teens with MS. The progressive nature of the cognitive difficulties emphasizes the need for developing effective treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20876467     DOI: 10.1212/WNL.0b013e3181f4d821

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  47 in total

1.  Multiple sclerosis: Which MRI findings predict MS development in children?

Authors:  E Ann Yeh
Journal:  Nat Rev Neurol       Date:  2012-02-28       Impact factor: 42.937

2.  Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network.

Authors:  L E Charvet; E H O'Donnell; A L Belman; T Chitnis; J M Ness; J Parrish; M Patterson; M Rodriguez; E Waubant; B Weinstock-Guttman; L B Krupp
Journal:  Mult Scler       Date:  2014-03-31       Impact factor: 6.312

3.  Normative values of the Rao's Brief Repeatable Battery in an Italian young adolescent population: the influence of age, gender, and education.

Authors:  Fabrizia Falco; Marcello Moccia; Alessandro Chiodi; Antonio Carotenuto; Angelo D'Amelio; Laura Rosa; Kyrie Piscopo; Andrea Falco; Teresa Costabile; Francesca Lauro; Vincenzo Brescia Morra; Roberta Lanzillo
Journal:  Neurol Sci       Date:  2019-01-15       Impact factor: 3.307

4.  Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT).

Authors:  J Burman; K Kirgizov; K Carlson; M Badoglio; G L Mancardi; G De Luca; B Casanova; J Ouyang; R Bembeeva; J Haas; P Bader; J Snowden; D Farge
Journal:  Bone Marrow Transplant       Date:  2017-03-20       Impact factor: 5.483

5.  Development and psychometric properties of the PROMIS(®) pediatric fatigue item banks.

Authors:  Jin-Shei Lai; Brian D Stucky; David Thissen; James W Varni; Esi Morgan DeWitt; Debra E Irwin; Karin B Yeatts; Darren A DeWalt
Journal:  Qual Life Res       Date:  2013-02-02       Impact factor: 4.147

Review 6.  Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.

Authors:  Amy Waldman; Angelo Ghezzi; Amit Bar-Or; Yann Mikaeloff; Marc Tardieu; Brenda Banwell
Journal:  Lancet Neurol       Date:  2014-09       Impact factor: 44.182

7.  The educational impact of childhood-onset multiple sclerosis: Why assessing academic achievement is imperative.

Authors:  W S Vargas; K G Noble; B Banwell; P De Jager
Journal:  Mult Scler       Date:  2020-05-28       Impact factor: 6.312

Review 8.  Disease-modifying therapy of pediatric multiple sclerosis.

Authors:  Tanuja Chitnis
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

9.  Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network.

Authors:  Laura Julian; Dana Serafin; Leigh Charvet; Joseph Ackerson; Ralph Benedict; Ellen Braaten; Tanya Brown; Ellen O'Donnell; Joy Parrish; Thomas Preston; Michael Zaccariello; Anita Belman; Tanuja Chitnis; Mark Gorman; Jayne Ness; Marc Patterson; Moses Rodriguez; Emmanuelle Waubant; Bianca Weinstock-Guttman; Ann Yeh; Lauren B Krupp
Journal:  J Child Neurol       Date:  2012-11-15       Impact factor: 1.987

10.  No evidence of disease activity including cognition (NEDA-3 plus) in naïve pediatric multiple sclerosis patients treated with natalizumab.

Authors:  Monica Margoni; Francesca Rinaldi; Alice Riccardi; Silvia Franciotta; Paola Perini; Paolo Gallo
Journal:  J Neurol       Date:  2019-09-27       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.